Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Этиологическая роль вируса папилломы человека в развитии рака шейки матки: генетические и патогенетические механизмы, возможности терапии и профилактики
Этиологическая роль вируса папилломы человека в развитии рака шейки матки: генетические и патогенетические механизмы, возможности терапии и профилактики
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Полный текст
Список литературы
1. Киселев В.И., Киселев О.И. Вирусы папилломы человека в развитии рака шейки матки. СПб.–М.: Роза мира, 2003.
2. McCance DJ. Human papillomavirus (HPV) infection in the aetiology of cervical cancer. Cancer Sury 19884 7: 499–506.
3. Bedell MA, Jones KH, Laimins LA. The E6-E7 region of hu man papillomavirus type 18 is sufficient for transformation of NIH 3T3 and rat-1 cells. J Virol 1987; 61: 3635–40.
4. Reeves WG, Rawls WE, Brinton LA. Epidemiology of genital papillomavirus and cervical cancer. Rev Infect Dis 1989; 11: 426–39.
5. Phelps WC, Barnes JA and Loba DC. Human papillomavirus: molecular targets and prospects for antiviral therapy. Internat Antiviral News 1999; 7: 4–8.
6. Young-Sik Cho, Jeong-Woo Kang, MinChul Cho et al. Down modulation of EL-18 expession by human papillomavirus type 16 E6 oncogene via binding to IL-18. FEBS Letters 2001; 501: 139–45.
7. Cram EJ, Liu BD, Bjeldanes LF, Firestone GL. Indole-3-carbinol inhibits CDK6 expression in human MCF-7 breast cancer cells by disrupting Spl transcription factor interactions with a composite element in the CDK6 gene promoter, J Biol Chem 2001 Apr 10 [epub ahead of print].
8. Lawrence JA, Malpas PB, Sigman CC, Kelloff GJ. Clinical development of estrogen modulators for breast cancer chemoprevention in premenopausal vs. postmenopausal women. J Cell Biochem 2000; 34 (Suppl.): 103–14.
9. Meng Q, Goldberg ID, Rosen EM, Fan S. Inhibitory effects of Indole-3-carbinol on invasion and migration in human breast cancer cells Breast Cancer Res Treat. 2000 Sep; 63 (2): 147–52.
10. Liang Jin, Mei Qi, Da-Zhi Chen et al. Indol-3-carbinol prevents cervical cancer in human papilloma virus type 16 (HPV 16) transgenic mice. Cancer Research 1999; 59: 3991–7.
11. Yuan F, ChenDZ, Liu К et al. Anti-estrogenic activities of indol-3-carbinol in cervical cells: implication for prevention of cervical cancer. Cancer Research 1999; 19 (3a): 1673–80.
12. Bell MC, Crowley-Nowick R, Bradlow HL et a. Placebo-Controlled Trail of indol-3-carbinol in the treatment of CIN (cervix cancer). Gynecologic Oncology 2000; 78: 123–9.
2. McCance DJ. Human papillomavirus (HPV) infection in the aetiology of cervical cancer. Cancer Sury 19884 7: 499–506.
3. Bedell MA, Jones KH, Laimins LA. The E6-E7 region of hu man papillomavirus type 18 is sufficient for transformation of NIH 3T3 and rat-1 cells. J Virol 1987; 61: 3635–40.
4. Reeves WG, Rawls WE, Brinton LA. Epidemiology of genital papillomavirus and cervical cancer. Rev Infect Dis 1989; 11: 426–39.
5. Phelps WC, Barnes JA and Loba DC. Human papillomavirus: molecular targets and prospects for antiviral therapy. Internat Antiviral News 1999; 7: 4–8.
6. Young-Sik Cho, Jeong-Woo Kang, MinChul Cho et al. Down modulation of EL-18 expession by human papillomavirus type 16 E6 oncogene via binding to IL-18. FEBS Letters 2001; 501: 139–45.
7. Cram EJ, Liu BD, Bjeldanes LF, Firestone GL. Indole-3-carbinol inhibits CDK6 expression in human MCF-7 breast cancer cells by disrupting Spl transcription factor interactions with a composite element in the CDK6 gene promoter, J Biol Chem 2001 Apr 10 [epub ahead of print].
8. Lawrence JA, Malpas PB, Sigman CC, Kelloff GJ. Clinical development of estrogen modulators for breast cancer chemoprevention in premenopausal vs. postmenopausal women. J Cell Biochem 2000; 34 (Suppl.): 103–14.
9. Meng Q, Goldberg ID, Rosen EM, Fan S. Inhibitory effects of Indole-3-carbinol on invasion and migration in human breast cancer cells Breast Cancer Res Treat. 2000 Sep; 63 (2): 147–52.
10. Liang Jin, Mei Qi, Da-Zhi Chen et al. Indol-3-carbinol prevents cervical cancer in human papilloma virus type 16 (HPV 16) transgenic mice. Cancer Research 1999; 59: 3991–7.
11. Yuan F, ChenDZ, Liu К et al. Anti-estrogenic activities of indol-3-carbinol in cervical cells: implication for prevention of cervical cancer. Cancer Research 1999; 19 (3a): 1673–80.
12. Bell MC, Crowley-Nowick R, Bradlow HL et a. Placebo-Controlled Trail of indol-3-carbinol in the treatment of CIN (cervix cancer). Gynecologic Oncology 2000; 78: 123–9.
Авторы
В.И.Киселев, Л.А.Ашрафян, С.О.Бударина, О.И.Киселев, М.А.Пальцев, В.И.Кулаков,
В.Н.Прилепская
Институт молекулярной медицины Московской медицинской академии им. И.М.Сеченова (ректор – акад. РАН и РАМН М.А.Пальцев),
Научный центр рентгенорадиологии (дир. – акад. РАМН проф. В.П.Харченко) МЗ и СР РФ
Научный центр акушерства, гинекологии и перинатологии
(дир. – акад. РАМН В.И.Кулаков) РАМН, Москва
В.Н.Прилепская
Институт молекулярной медицины Московской медицинской академии им. И.М.Сеченова (ректор – акад. РАН и РАМН М.А.Пальцев),
Научный центр рентгенорадиологии (дир. – акад. РАМН проф. В.П.Харченко) МЗ и СР РФ
Научный центр акушерства, гинекологии и перинатологии
(дир. – акад. РАМН В.И.Кулаков) РАМН, Москва
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.